Benjamin Matthew Vierra, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Liposarcoma, Myxoid | 1 | 2023 | 60 | 0.870 |
Why?
|
Liposarcoma | 1 | 2023 | 289 | 0.720 |
Why?
|
Gastric Bypass | 3 | 2024 | 818 | 0.600 |
Why?
|
Obesity, Morbid | 3 | 2024 | 1277 | 0.590 |
Why?
|
Soft Tissue Neoplasms | 1 | 2023 | 1159 | 0.470 |
Why?
|
Laparoscopy | 2 | 2023 | 2036 | 0.460 |
Why?
|
Bariatric Surgery | 2 | 2024 | 992 | 0.440 |
Why?
|
Hip Prosthesis | 1 | 2017 | 921 | 0.370 |
Why?
|
Prosthesis Design | 1 | 2017 | 2115 | 0.350 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1413 | 0.270 |
Why?
|
Gastroesophageal Reflux | 2 | 2024 | 819 | 0.270 |
Why?
|
Manometry | 2 | 2024 | 454 | 0.240 |
Why?
|
Gastrectomy | 3 | 2024 | 672 | 0.230 |
Why?
|
Octreotide | 1 | 2024 | 153 | 0.220 |
Why?
|
Pancreatic Fistula | 1 | 2024 | 148 | 0.220 |
Why?
|
Somatostatin | 1 | 2024 | 447 | 0.200 |
Why?
|
Reoperation | 2 | 2022 | 4303 | 0.170 |
Why?
|
Pancreatectomy | 1 | 2024 | 811 | 0.170 |
Why?
|
Chemotherapy, Cancer, Regional Perfusion | 1 | 2019 | 94 | 0.160 |
Why?
|
Carcinoma, Large Cell | 1 | 2019 | 113 | 0.150 |
Why?
|
Corrosion | 1 | 2017 | 26 | 0.150 |
Why?
|
Colorectal Surgery | 1 | 2019 | 122 | 0.140 |
Why?
|
Carcinoma, Small Cell | 1 | 2019 | 420 | 0.140 |
Why?
|
Hyperthermia, Induced | 1 | 2019 | 417 | 0.130 |
Why?
|
Lipopolysaccharides | 1 | 2023 | 2206 | 0.130 |
Why?
|
Preoperative Care | 1 | 2024 | 2242 | 0.120 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 339 | 0.120 |
Why?
|
Peritoneal Neoplasms | 1 | 2019 | 711 | 0.110 |
Why?
|
Postoperative Complications | 3 | 2024 | 15633 | 0.100 |
Why?
|
Neuroendocrine Tumors | 1 | 2019 | 641 | 0.100 |
Why?
|
Trees | 1 | 2012 | 55 | 0.100 |
Why?
|
Prosthesis Failure | 1 | 2017 | 1204 | 0.100 |
Why?
|
Biodiversity | 1 | 2012 | 347 | 0.080 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 11742 | 0.080 |
Why?
|
Patient Readmission | 1 | 2022 | 3271 | 0.080 |
Why?
|
Carcinoma | 1 | 2019 | 2330 | 0.080 |
Why?
|
Retrospective Studies | 4 | 2024 | 80646 | 0.070 |
Why?
|
Lymph Nodes | 1 | 2019 | 3466 | 0.070 |
Why?
|
Colonic Neoplasms | 1 | 2019 | 2538 | 0.070 |
Why?
|
Climate Change | 1 | 2012 | 501 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11121 | 0.060 |
Why?
|
Esophageal pH Monitoring | 1 | 2024 | 202 | 0.050 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9280 | 0.040 |
Why?
|
Models, Theoretical | 1 | 2012 | 3575 | 0.040 |
Why?
|
Gastrointestinal Agents | 1 | 2024 | 510 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6935 | 0.040 |
Why?
|
Humans | 9 | 2024 | 761572 | 0.040 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 8528 | 0.040 |
Why?
|
Health Care Surveys | 1 | 2024 | 2426 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2023 | 36429 | 0.030 |
Why?
|
Female | 5 | 2024 | 392686 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 23996 | 0.030 |
Why?
|
Adult | 3 | 2024 | 221203 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12725 | 0.030 |
Why?
|
Middle Aged | 4 | 2024 | 220920 | 0.030 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3597 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2019 | 39107 | 0.020 |
Why?
|
Treatment Outcome | 2 | 2024 | 64684 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2012 | 2330 | 0.010 |
Why?
|
Male | 4 | 2024 | 360842 | 0.010 |
Why?
|
Prognosis | 1 | 2024 | 29629 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2024 | 26127 | 0.010 |
Why?
|
Computer Simulation | 1 | 2012 | 6241 | 0.010 |
Why?
|
United States | 1 | 2024 | 72335 | 0.010 |
Why?
|
Models, Biological | 1 | 2012 | 9469 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 54426 | 0.010 |
Why?
|
Aged | 1 | 2019 | 169310 | 0.000 |
Why?
|